Clinical Trial Update: MEDCEM PC and MTA in Pulpotomies of Primary Molars [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating MEDCEM PC versus MTA in pulpotomies of primary molars; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulpitis

Drugs mentioned

• MEDCEM PC
• MTA (mineral trioxide aggregate)

Snippet

Sponsor: Universitat Internacional de Catalunya | Conditions: Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars. | Phase 4 | Status: UNKNOWN